Screener
Lantern Pharma LTRN Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
EPS-$0.36Beat by $0.10
EPS estimate-$0.46
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Lantern Pharma report Q4 2025 earnings?
- Lantern Pharma (LTRN) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were Lantern Pharma's Q4 2025 revenue and EPS?
- Lantern Pharma reported eps of $-0.36 for Q4 2025.
- Did Lantern Pharma beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.46 by $0.10.
- How did Lantern Pharma's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 33.3% from $-0.54.
- Where can I find Lantern Pharma's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-013608) and the 10-K periodic report (0001493152-26-013612) directly on SEC EDGAR. The filing index links above go to sec.gov.
